UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development and validation of a LC-MS/MS method for the simultaneous determination of aflatoxins, dyes and pesticides in spices

Analytical and bioanalytical chemistry, 2010-05, Vol.397 (1), p.93-107

2010

Volltextzugriff (PDF)

A German multicenter, randomized phase III trial comparing irinotecan–carboplatin with etoposide–carboplatin as first-line therapy for extensive-disease small-cell lung cancer

Annals of oncology, 2011-08, Vol.22 (8), p.1798-1804

2011

Volltextzugriff (PDF)

Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study

Annals of oncology, 2013-04, Vol.24 (4), p.986-992

2013

Volltextzugriff (PDF)

Erythrocyte sedimentation rate as an independent prognostic factor in mycosis fungoides

British journal of dermatology (1951), 2012-04, Vol.166 (4), p.873-874

2012

Volltextzugriff (PDF)

ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer

Annals of oncology, 2020-05, Vol.31 (5), p.609-618

2020

Volltextzugriff (PDF)

A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer

Annals of oncology, 2008-05, Vol.19 (5), p.939-945

2008

Volltextzugriff (PDF)

Third CECOG consensus on the systemic treatment of non-small-cell lung cancer

Annals of oncology, 2012-05, Vol.23 (5), p.1223-1229

2012

Volltextzugriff (PDF)

Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma

International journal of cancer, 2019-01, Vol.144 (1), p.190-199

2019

Volltextzugriff (PDF)

Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2014-04, Vol.84 (1), p.62-66

2014

Volltextzugriff (PDF)

Nitrogen cycling and metabolism in the thalweg of a prairie river

Journal of Geophysical Research - Biogeosciences, 2008-12, Vol.113 (G4), p.G04029-n/a

2008

Volltextzugriff (PDF)

Adaptive Dead-Time Compensation for Grid-Connected PWM Inverters of Single-Stage PV Systems

IEEE transactions on power electronics, 2013-06, Vol.28 (6), p.2816-2825

2013

Volltextzugriff (PDF)

Docetaxel–carboplatin chemotherapy combined with cetuximab in patients with locally advanced or metastatic non small-cell lung cancer (NSCLC)—Results of the nonrandomised phase II study TaxErb

Lung cancer (Amsterdam, Netherlands), 2012-03, Vol.75 (3), p.348-352

2012

Volltextzugriff (PDF)

Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)

Annals of oncology, 2016-10, Vol.27 (10), p.1895-1902

2016

Volltextzugriff (PDF)

Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing

Lung cancer (Amsterdam, Netherlands), 2020-10, Vol.148, p.105-112

2020

Volltextzugriff (PDF)

Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis

The European respiratory journal, 2010-02, Vol.35 (2), p.381-390

2010

Volltextzugriff (PDF)

SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer

Annals of oncology, 2017-12, Vol.28 (12), p.3028-3036

2017

Volltextzugriff (PDF)

Prognostic significance of cytokine modulation in non‐small cell lung cancer

International journal of cancer, 2002-09, Vol.101 (3), p.287-292

2002

Volltextzugriff (PDF)

ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in≥3L advanced NSCLC treatment

Annals of oncology, 2018-10, Vol.29, p.viii493-viii494

2018

Volltextzugriff (PDF)

Durvalumab in frail and elder patients with stage four NSCLC: The DURATION trial

Annals of oncology, 2018-10, Vol.29, p.viii546-viii547

2018

Volltextzugriff (PDF)

Generalised predictive current‐mode control of passive front‐end boost‐type converters

IET power electronics, 2021-02, Vol.14 (3), p.666-679

2021

Volltextzugriff (PDF)

Risk-profile and outcome of small papillary and follicular thyroid carcinomas (<or=1 cm)

Nuclear medicine, 2008-01, Vol.47 (5), p.188-193

2008

Volltextzugriff (PDF)

Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer: The FORCE trial

Annals of oncology, 2018-10, Vol.29, p.viii544-viii544

2018

Volltextzugriff (PDF)

A Comparative Study of the Removal of Heavy Metal Ions from Water Using a Silica−Polyamine Composite and a Polystyrene Chelator Resin

Industrial & engineering chemistry research, 1999-11, Vol.38 (11), p.4402-4408

1999

Volltextzugriff (PDF)

TP53 mutations impair overall survival of TKI-treated patients with oncogene-driven NSCLC

Annals of oncology, 2018-10, Vol.29, p.viii516-viii517

2018

Volltextzugriff (PDF)

Lead toxicosis and trace element levels in wild birds and mammals at a firearms Training facility

Archives of environmental contamination and toxicology, 2001-08, Vol.41 (2), p.208-214

2001

Volltextzugriff (PDF)

1 – 25 von 17.969

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15.073)
Mit Volltextzugriff
(14.754)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(9.991)
Life Sciences & Biomedicine
(5.836)
Humans
(4.577)
Physical Sciences
(3.423)
Female
(2.691)
Male
(2.567)
Physics
(2.478)
Biological And Medical Sciences
(2.367)
Medical Sciences
(1.718)
Adult
(1.682)
Animals
(1.619)
Technology
(1.573)
Middle Aged
(1.534)
Physics Of Elementary Particles And Fields
(1.136)
Aged
(1.044)
Exact Sciences And Technology
(1.002)
Fundamental And Applied Biological Sciences. Psychology
(787)
Physics, Particles & Fields
(729)
Chemistry
(710)
Adolescent
(690)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(7.137)
IngentaConnect Journals
(6.597)
MEDLINE
(6.043)
Journals@Ovid
(4.097)
Publisher or Other Site
(3.624)
Elsevier ScienceDirect Journals Complete
(3.248)
Springer Nature - Complete Springer Journals
(2.659)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2.451)
IngentaConnect Journals
(2.051)
Wiley Online Library Journals Frontfile Complete
(1.873)
Wiley Online Library Full Collection 2018
(1.284)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.050)
American Physical Society Journals
(830)
IEEE/IET Electronic Library
(711)
JSTOR
(663)
Oxford Journals
(651)
PROLA
(630)
Ebook Central Perpetual and DDA
(623)
eBooks on EBSCOhost
(605)
Nature Journals
(457)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of High Energy Physics
(601)
The European Physical Journal. C, Particles And Fields
(556)
Physics Letters. B
(502)
Physical Review Letters
(290)
The Astrophysical Journal
(181)
Physical Review. D
(176)
Journal Of High Energy Physics
(133)
Applied Physics Letters
(105)
Science
(103)
Nature
(99)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Development and validation of a LC-MS/MS method for the simultaneous determination of aflatoxins, dyes and pesticides in spices

A German multicenter, randomized phase III trial comparing irinotecan–carboplatin with etoposide–carboplatin as first-line therapy for extensive-disease small-cell lung cancer

Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study

Erythrocyte sedimentation rate as an independent prognostic factor in mycosis fungoides

ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer

A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer

Third CECOG consensus on the systemic treatment of non-small-cell lung cancer

Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma

Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer

Nitrogen cycling and metabolism in the thalweg of a prairie river

Adaptive Dead-Time Compensation for Grid-Connected PWM Inverters of Single-Stage PV Systems

Docetaxel–carboplatin chemotherapy combined with cetuximab in patients with locally advanced or metastatic non small-cell lung cancer (NSCLC)—Results of the nonrandomised phase II study TaxErb

Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)

Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing

Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis

SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer

Prognostic significance of cytokine modulation in non‐small cell lung cancer

ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in≥3L advanced NSCLC treatment

Durvalumab in frail and elder patients with stage four NSCLC: The DURATION trial

Generalised predictive current‐mode control of passive front‐end boost‐type converters

Risk-profile and outcome of small papillary and follicular thyroid carcinomas (<or=1 cm)

Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer: The FORCE trial

A Comparative Study of the Removal of Heavy Metal Ions from Water Using a Silica−Polyamine Composite and a Polystyrene Chelator Resin

TP53 mutations impair overall survival of TKI-treated patients with oncogene-driven NSCLC

Lead toxicosis and trace element levels in wild birds and mammals at a firearms Training facility

Suchergebnisse filtern